adopted targeted alpha therapy (TAT) as a promising alternative to conventional beta therapy. They developed an astatine-211 (211 At)-labeled peptide drug that could offer a potential breakthrough ...

On the left are the representative images of TTC-stained tissues from mice treated with the Tat-SIRT5-CTM peptide. In the center is the mNSS results showing the extent of neurological deficits at ...